Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 29 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
24 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
CARDIAC RESEARCH INSTITUTE from Aalst, company number BE0629850791, closed financial year 2025 with a result of € 313,819 after tax. For that financial year CARDIAC RESEARCH INSTITUTE recorded a gross margin of € 454,497 and equity of € 206,225. Compared with financial year 2024, the result moved from € 186,300 to € 313,819. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.
€ 206,225
▼ 19% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 313,819
▲ 68% vs 2024
Profit after tax over the fiscal year.
€ 115,230
▼ 88% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 435,644 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
0.4
Average over the fiscal year, from the social balance sheet.
€ 28,529
▲ 5% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 86,717
▼ 87% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 52,102
▼ 40% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 172,526 | € 141,133 | € 275,688 | € 454,497 | ▲ 65% |
| Profit after taxes | € 99,714 | € 35,220 | € 186,300 | € 313,819 | ▲ 68% |
| Equity | € 466,745 | € 501,965 | € 253,050 | € 206,225 | ▼ 19% |
| Total debts | € 1,607,552 | € 1,739,153 | € 1,842,162 | € 1,657,396 | ▼ 10% |
| Cash | € 1,479,103 | € 499,123 | € 967,426 | € 115,230 | ▼ 88% |
| Retained profit | € 394,245 | € 429,465 | € 185,644 | € 63,819 | ▼ 66% |
| Dividend | € 0 | € 0 | € 429,465 | € 435,644 | ▲ 1% |
| Balance sheet total | € 2,074,297 | € 2,241,119 | € 2,095,212 | € 1,863,621 | ▼ 11% |
| Employees (FTE) | 0.4 | 0.4 | 0.4 | 0.4 |
Key figures of CARDIAC RESEARCH INSTITUTE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to CARDIAC RESEARCH INSTITUTE?
What happened at CARDIAC RESEARCH INSTITUTE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Dr. T. De Potter bv stepped down as director. NBB
- Dr. W. Heggermont, Cardiologie bv stepped down as director. NBB
- Dicentra bv stepped down as director. NBB
- Dr. E. Wyffels bv stepped down as director. NBB
- Dokter Peter Peytchev bv stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 313,819 (▲ 68% vs 2024). Source: NBB ↗
- Dr. T. De Potter bv became a director. NBB
- Dr. W. Heggermont, Cardiologie bv became a director. NBB
In short
From € 99,714 profit in 2022 to € 313,819 profit in 2025.
Paid € 258,251 in corporate taxes since 2022.
Best year ever: 2025, with € 313,819 profit.
Paid out € 865,110 in dividends to the owners in total.
A new publication or filing at CARDIAC RESEARCH INSTITUTE? We notify you, reason included.
Follow CARDIAC RESEARCH INSTITUTEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Dokter J.SONCK Cardiologie comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
CARDIAC RESEARCH INSTITUTEThe shares are held by Dokter J.SONCK Cardiologie (100%).
Directors
According to the 2025 annual accounts
Director · represented by Tom De Potter
since 2024 · until 2029
Dr. W. Heggermont, Cardiologie bv
Director · represented by Ward Heggermont
since 2024 · until 2029
Director · represented by Jozef Bartúnek
since 2024 · until 2029
Director · represented by Eric Wyffels
since 2024 · until 2029
Director · represented by Peter Peytchev
since 2024 · until 2029
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Moorselbaan 164
9300 Aalst
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 24 companies are registered at this address.
All companies at this address →Onze-Lieve-Vrouwziekenhuis
€ 0 revenue · 2025
Vakantiedialyse
Cardiovascular Research Center Aalst
€ 173,775 gross margin · 2025
NEUROCHIRURGIE
OLV RESEARCH UNIT
€ -57,102 gross margin · 2022
+19 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
COMBELL-AS, BE
Website info
Features
Security
Network
Details
- Company number
- 0629.850.791
- VAT number
- BE 0629.850.791
- Registered office
- Moorselbaan 164, 9300 Aalst
- Names & denominations
- CARDIAC RESEARCH INSTITUTE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 7 May 2015
- Peppol
- Active · Active since 9 Feb 2026
- Contact
- hartvoorresearchaalst.be
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied